The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Hansa Biopharma AB, “announced the acceptance by the U.S. FDA of Hansa’s Investigational New Drug (IND) application to proceed with a Phase 3 study of...
read more
Agilent Technologies Inc. has joined the National Institute for Innovation in Manufacturing to Advance Biomanufacturing (NIIMBL). Membership in NIIMBL...
read more
Wednesday, April 20, 2022
Dragonfly Therapeutics, Inc. announced an expansion of its research collaboration with AbbVie to discover and develop Dragonfly's novel ...
read more
Wednesday, April 20, 2022
Arcturus Therapeutics Holdings Inc. announced topline data from an ongoing Phase 1/2/3 trial evaluating ARCT-154, Arcturus’ self-amplifying mRNA ...
read more
Wednesday, April 20, 2022
Merck announced that Joseph Romanelli will lead Human Health International, and join Merck’s Executive Team, effective August 1, 2022.
read more
Detailed results from the PROVENT Phase III pre-exposure prophylaxis (prevention) trial showed that AstraZeneca’s Evusheld (tixagevimab and cilgavimab...
read more
Breckenridge Pharmaceutical, Inc. has launched Pencillamine Capsules, USP (generic for Cuprimine®).
read more
Novavax, Inc. announced initial results from the Phase 1/2 clinical trial of its COVID-Influenza Combination Vaccine (CIC). The CIC combines Novavax' ...
read more
The FDA announced it is seeking public comment on a potential change that would require opioid analgesics used in outpatient settings to be dispensed ...
read more
Zambon announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to colistimethate sodium powder for ...
read more
Direct Biologics announced that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo,...
read more
Novavax, Inc. has initiated administration of the first booster doses of NVX-CoV2373, the company's protein-based COVID-19 vaccine, in the pediatric ...
read more
The University of Tokyo and Astellas Pharma Inc. have entered the second phase of their collaboration for co-creating innovative new medicines and ...
read more
AstraZeneca’s Biologics License Application (BLA) for tremelimumab has been accepted for Priority Review in the US, supporting the indication of a ...
read more
Merck announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending...
read more